Stocks: 503 Market Cap: $51.2T S&P 500: 5,954.50 +0.82%
500 500Market
Gilead Sciences
GILD Rank #58 Health Care
$148.22 +0.26%

Key Statistics

Market Cap
$184.00B
Volume (24h)
$1.1B
P/E Ratio
21.8
EPS
$6.80
1 Day
+0.26%
7 Day
+0.39%
YTD
+22.83%
Sector
Health Care
S&P 500 Rank
#58
52W Low: $102.52 52W High: $199.85

About Gilead Sciences

Gilead Sciences is a biopharmaceutical company that develops, manufactures, and commercializes therapies for the treatment of life-threatening infectious diseases, including HIV/AIDS, liver diseases, and cancer. The company's key products include Sovaldi, Harvoni, Epclusa, and Biktarvy, which are used to treat various viral infections and cancers. As a leader in the development of antiviral therapies, Gilead Sciences plays a significant role in improving patient outcomes and addressing some of the world's most pressing public health challenges.

Latest News

Loading latest news...

Sector Peers — Health Care

LLY — Lilly (Eli) $1,003.57 -0.41% JNJ — Johnson & Johnson $245.30 -0.59% ABBV — AbbVie $236.19 +1.00% MRK — Merck & Co. $120.28 +0.38% UNH — UnitedHealth Group $291.96 +0.95% AMGN — Amgen $379.27 +0.60% ABT — Abbott Laboratories $113.10 -0.45% TMO — Thermo Fisher Scientific $512.69 +0.90% View all Health Care stocks →

Daily Market Brief

S&P 500 closing prices, top movers, and sector performance — delivered daily.